Tushar Mishra
Interventional Cardiology · Birmingham, ALNPI 1629504873
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (55.8%), grants and education — rather than concentrated in one kind of arrangement. 39 manufacturers reported payments, led by Abbott at 46.7% of the total. Reporting peaked in 2024 at $11,348 and has fallen 66.8% since, to $3,765 in 2025.
Across 268 payments — averaging $65.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$8K
- Shockwave Medical, Inc$2K
- Medtronic$789
- Abiomed$670
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$578
- Boston Scientific$573
- plus $5K from 33 others
What the payments were for
- Grants$7,50043%
- Travel & lodging$100%
- Food & beverage$9,75256%
- Education$2161%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 21 | $8,168 |
| Shockwave Medical, Inc | 33 | $1,834 |
| Medtronic | 25 | $789 |
| Abiomed | 18 | $670 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 19 | $578 |
| Boston Scientific | 10 | $573 |
| Bard Peripheral Vascular, Inc. | 14 | $509 |
| Biotronik Inc. | 10 | $390 |
| Inari Medical, Inc. | 3 | $372 |
| Amgen | 12 | $365 |
| Chiesi USA, Inc. | 11 | $314 |
| Cardiva Medical, Inc. | 11 | $312 |
| Terumo Medical Corporation | 11 | $277 |
| Novo Nordisk | 2 | $250 |
| Angiodynamics, Inc. | 5 | $203 |
| AstraZeneca | 10 | $164 |
| Penumbra, Inc. | 5 | $161 |
| Lantheus Medical Imaging, Inc. | 5 | $134 |
| Philips North America LLC | 5 | $133 |
| Janssen Scientific Affairs, LLC | 1 | $133 |
| Recordati_rare_diseases_inc. | 1 | $125 |
| Boehringer Ingelheim | 1 | $121 |
| Johnson & Johnson | 6 | $115 |
| Cook Medical LLC | 3 | $102 |
| Pfizer | 5 | $81 |
| W. L. Gore & Associates, Inc. | 2 | $80 |
| Esperion Therapeutics, Inc. | 1 | $78 |
| Cordis US CORP. | 3 | $68 |
| Stryker | 3 | $64 |
| Teleflex LLC | 2 | $50 |
| Novartis | 2 | $47 |
| Edwards Lifesciences | 1 | $43 |
| Imperative Care, Inc | 1 | $38 |
| Asahi Intecc USA, Inc. | 1 | $28 |
| Sanofi-aventis U.S. LLC | 1 | $27 |
| E.r. Squibb & Sons, L.L.C. | 1 | $26 |
| Melinta Therapeutics, LLC | 1 | $23 |
| Merck | 1 | $16 |
| Ardelyx, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XIENCE V$7,500
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$959
- FLOWTRIEVER CATHETER, S$330
- CT THROMBECTOMY SYSTEM KIT$330
- WATCHMAN FLX$155
- EMBLEM MRI S-ICD$140
- LifeStent Solo Vascular Stent$133
- XARELTO$133
- Ozempic$125
- Sylvant$125
- JARDIANCE$121
- Repatha$120
- XIENCE SKYPOINT$103
How this compares
$17,477 in reported general payments places this provider in the 75th percentile of 109 interventional cardiology providers in Alabama.
Other interventional cardiology in Birmingham
- Gary RoubinBirmingham$157K
- Robert FosterBirmingham$90K
- Hasan GuvenBirmingham$86K
- Abdullah MahmoodBirmingham$61K
- Ali EbrahimiBirmingham$55K
- Jacob TownsendBirmingham$52K
- Kamran AliBirmingham$47K
- Mouhamed SabouniBirmingham$44K
- David SchultzBirmingham$19K
- Arka ChatterjeeBirmingham$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.